Recursion Pharmaceuticals RXRX Income Statement (2020-2026)

NASDAQ RXRX
$3.65 +0.21 (+6.22%)
As of: Sep 4, 2026 · 11:49 AM EDT
Reported Financials

Recursion Pharmaceuticals Quarterly Income Statement

Periods 26 quarters
Latest Jun 2026

Recursion Pharmaceuticals reported revenue of $7.67M and net income of -$131.00M for the quarter ended Jun 2026, down 60.1% year over year. This income statement covers 26 quarters of results from Mar 2020 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Income Statement Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Revenue & cost
Revenue
2.53M2.53M5.33M7.67M13.16M13.68M12.13M11.02M10.53M10.89M13.79M14.42M26.08M4.55M14.74M19.22M5.17M35.54M6.47M7.67M
Cost of RevenueCost of Rev
7.80M14.23M15.41M10.84M12.45M9.38M10.88M9.88M11.17M9.20M12.08M12.79M21.83M20.16M14.69M14.28M12.49M11.49M
Gross Profit
2.53M2.53M-2.47M-6.55M-2.25M2.84M-0.31M1.64M-0.34M1.01M2.63M5.22M14.00M-8.25M-7.08M-0.94M-9.51M21.26M-6.02M-3.82M
Operating items
Research & DevelopmentR&D
33.25M48.29M32.44M38.44M40.84M43.98M46.68M55.06M70.01M69.48M67.56M73.93M74.60M98.33M129.63M128.64M121.06M95.94M87.90M89.61M
Selling, General & AdministrativeSG&A
15.69M19.20M21.07M21.20M19.49M19.84M22.87M28.29M29.20M30.46M31.41M31.83M37.76M77.19M54.65M46.65M41.63M33.66M34.59M41.53M
Other Operating ExpensesOther Opex
7.80M14.23M15.41M10.84M12.45M9.38M10.88M9.88M11.17M9.20M12.08M12.79M21.83M20.16M14.69M14.28M12.49M11.49M
Operating ExpensesOpex
48.94M67.49M61.31M73.86M75.73M74.66M82.00M92.73M110.08M109.82M110.13M114.96M124.44M188.31M206.11M195.45M177.38M143.87M134.98M142.64M
Operating IncomeOp. Inc
-46.40M-64.96M-55.98M-66.19M-62.57M-60.98M-69.86M-81.72M-99.55M-98.93M-96.34M-100.54M-98.35M-183.77M-191.37M-176.23M-172.20M-108.33M-128.50M-134.97M
EBIT
-46.40M-64.96M-55.98M-66.19M-62.57M-60.98M-69.86M-81.72M-99.55M-98.93M-96.34M-100.54M-98.35M-183.77M-191.37M-176.23M-172.20M-108.33M-128.50M-134.97M
Non-operating items
Non Operating IncomeNon Op. Inc.
-1.03M0.03M0.00M0.63M2.13M3.49M4.54M4.99M6.53M1.87M4.19M2.48M2.68M4.87M-11.28M4.33M9.95M0.23M6.40M3.96M
Net income details
EBT
-46.40M-64.96M-55.98M-66.19M-62.57M-60.98M-65.33M-76.73M-93.02M-97.06M-92.15M-98.06M-95.67M-178.90M-202.65M-171.90M-162.25M-108.10M-122.11M-131.01M
Tax ProvisionsTaxes
-4.06M-0.78M-0.52M0.17M0.01M-0.16M0.00M0.02M-4.60M-0.00M
Profit After TaxPAT
-47.43M-64.93M-55.98M-65.56M-60.45M-57.49M-65.33M-76.73M-93.02M-93.00M-91.37M-97.54M-95.84M-178.91M-202.49M-171.90M-162.25M-108.12M-117.50M-131.00M
Income from Non-Controlling InterestsInc. Minority
Income from Continuing OperationsIncome (Continuing)
-46.40M-64.96M-55.98M-66.19M-62.57M-60.98M-65.33M-76.73M-93.02M-93.00M-91.37M-97.54M-95.84M-178.91M-202.49M-171.90M-162.25M-108.12M-117.50M-131.00M
Consolidated Net IncomeConsol Net Inc.
-46.40M-64.96M-55.98M-66.19M-62.57M-60.98M-65.33M-76.73M-93.02M-93.00M-91.37M-97.54M-95.84M-178.91M-202.49M-171.90M-162.25M-108.12M-117.50M-131.00M
Income towards Parent CompanyParent Net Inc
-46.40M-64.96M-55.98M-66.19M-62.57M-60.98M-65.33M-76.73M-93.02M-93.00M-91.37M-97.54M-95.84M-178.91M-202.49M-171.90M-162.25M-108.12M-117.50M-131.00M
Net Income towards Common StockholdersNet Income
-46.40M-64.96M-55.98M-66.19M-62.57M-60.98M-65.33M-76.73M-93.02M-93.00M-91.37M-97.54M-95.84M-178.91M-202.49M-171.90M-162.25M-108.12M-117.50M-131.00M
Additional items
EPS (Basic)
-0.28-0.52-0.33-0.38-0.36-0.35-0.34-0.38-0.43-0.45-0.39-0.40-0.34-0.65-0.50-0.41-0.36-0.24-0.22-0.25
EPS (Diluted)
-0.28-0.52-0.33-0.38-0.36-0.35-0.34-0.38-0.43-0.45-0.39-0.40-0.34-0.65-0.50-0.41-0.36-0.24-0.22-0.25
Shares Outstanding
168.53M125.35M170.69M172.21M173.44M175.54M191.62M201.42M214.33M207.85M236.02M242.20M282.58M274.21M402.77M417.36M446.99M447.45M529.30M532.46M
Shares Outstanding (Diluted)Shares Outstanding (Dil.)
168.53M125.35M170.69M172.21M173.44M175.54M191.62M201.42M214.33M207.85M236.02M242.20M282.58M274.21M402.77M417.36M446.99M447.45M529.30M532.46M
Shares Outstanding (Entity)Shares Outstanding (Entity.)
168.63M170.27M171.08M172.82M174.07M191.02M192.23M206.74M216.31M234.27M237.51M280.97M286.12M396.51M406.41M432.83M491.80M528.18M530.63M534.12M
EBITDA
-46.40M-64.96M-55.98M-66.19M-62.57M-60.98M-69.86M-81.72M-99.55M-98.93M-96.34M-100.54M-98.35M-183.77M-191.37M-176.23M-172.20M-108.33M-128.50M-134.97M
Tax Rate
4.19%0.85%0.53%-0.17%0.00%0.08%0.00%-0.02%3.77%0.00%